Skip to main content
← Project catalogue

Free Starter Project

Asthma Annual Review and Reliever Overuse Audit

Free project — no credit required. Review the quality of asthma annual reviews, including control, reliever use, inhaler technique and personalised action plans.

FreeNew
Explore Catalogue

Overview

Free projects are complete and ready to use. Paid projects can also be adapted to your local requirements. This project uses a fixed Lazomis clinical configuration of 28 audit criteria across cohort and review context, asthma control assessment, exacerbation and risk review, reliever use and possible over-reliance, medicines review and adherence, inhaler technique, personalised action plan and self-management, triggers and wider review, and follow-up and escalation. Data collection, dashboards, findings, improvement planning, re-audit and every output are included at no cost.

Specialties, services & categories

Clinical specialties:General PracticeRespiratory MedicinePaediatricsPharmacy
Healthcare services:Primary Care NetworksCommunity ServicesPharmacyOutpatient ServicesClinical Governance
Categories:GovernancePatient Safety

Who should use it

  • GPs, practice nurses, clinical pharmacists, ACPs and physician associates
  • Respiratory nurses, community pharmacists and long-term condition leads
  • QI, clinical governance and service management teams
  • Trainees needing ARCP-ready evidence

Objectives

  • Measure whether asthma control is assessed using a structured or validated method
  • Review whether exacerbation history, urgent care use and higher-risk features are documented
  • Review reliever use, possible SABA over-reliance and the action taken where concern is identified
  • Review medicines, adherence, inhaler technique, personalised asthma action plans and follow-up
  • Generate governance-ready and ARCP-ready evidence

Data collected

  • Anonymised case number, review date, audit cycle and location
  • Age band, adult/young person/child category, care setting and register status
  • Asthma control method and status, exacerbations and urgent care use
  • Reliever strategy, SABA issue bands, technique method and action plan status
  • 28 fixed audit criteria (Yes / No / Not applicable)
  • Free-text learning points

Outputs generated

  • Live dashboard
  • Audit report (Word)
  • Executive summary (Word)
  • Excel workbook
  • PowerPoint presentation
  • Conference poster
  • ARCP evidence summary

Governance notes

  • Designed to use anonymised or pseudonymised audit identifiers.
  • This tool supports, but does not replace, clinical judgement.
  • Local policy, formulary and specialist advice should be followed.
  • Organisations remain responsible for local governance arrangements.
  • This tool supports clinical audit and quality improvement. It does not replace clinical judgement, local policy, local formulary, specialist advice or urgent escalation pathways.
  • Acute asthma symptoms, severe breathlessness, rapidly worsening asthma or suspected life-threatening asthma should be managed according to local urgent or emergency pathways.
  • Reliever-use signals are audit prompts only. SABA thresholds do not apply to ICS/formoterol reliever or MART regimens, and QOF indicators are not presented as the full clinical standard.
  • Use anonymous case identifiers only — never patient-identifiable information.

Lazomis QI supporting resources